Your browser doesn't support javascript.
loading
Chemotherapy and the Extra-Tumor Immune Microenvironment: EXTRA-TIME.
Phan, Tri Giang; Weilbaecher, Katherine N; Aft, Rebecca; Croucher, Peter I; Chaffer, Christine L.
Affiliation
  • Phan TG; Garvan Institute of Medical Research, Darlinghurst, New South Wales, Australia.
  • Weilbaecher KN; St. Vincent's Healthcare Clinical Campus, School of Clinical Medicine, Faculty of Medicine and Health, UNSW Sydney, Darlinghurst, New South Wales, Australia.
  • Aft R; Department of Medicine and Cell Biology and Physiology, Washington University School of Medicine, St. Louis, Missouri.
  • Croucher PI; Department of Surgery, Washington University School of Medicine, St. Louis, Missouri.
  • Chaffer CL; Garvan Institute of Medical Research, Darlinghurst, New South Wales, Australia.
Cancer Discov ; 14(4): 643-647, 2024 Apr 04.
Article in En | MEDLINE | ID: mdl-38571433
ABSTRACT

SUMMARY:

Understandably, conventional therapeutic strategies have focused on controlling primary tumors. We ask whether the cost of such strategies is actually an increased likelihood of metastatic relapse.
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Neoplasms Limits: Humans Language: En Journal: Cancer Discov Year: 2024 Type: Article Affiliation country: Australia
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Neoplasms Limits: Humans Language: En Journal: Cancer Discov Year: 2024 Type: Article Affiliation country: Australia